Joseph Todisco
Chief Executive Officer at CorMedix Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 5 years
- Director since
- 2023
5 years of board service in total across 2 boards, counting each seat separately. Longest: CorMedix Inc., 3 years.
CorMedix Inc.
Director · Chief Executive Officer
Talphera Inc.
Director
Chief executive roles
CorMedix Inc.
· Chief Executive Officer
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 22, 2026 | Talphera Inc. | Grant or award | +5,100 | — | — |
| Feb 4, 2026 | CorMedix Inc. | Grant or award | +77,156 | — | — |
| Jan 23, 2026 | CorMedix Inc. | Grant or award | +225,900 | — | — |
| Jan 23, 2026 | CorMedix Inc. | Shares withheld for tax | −27,306 | $7.27 | $198,515 |
| Jan 17, 2026 | CorMedix Inc. | Shares withheld for tax | −22,665 | $6.78 | $153,669 |
| Jan 16, 2026 | CorMedix Inc. | Option exercise | +29,585 | $3.38 | $99,997 |
| Jan 12, 2026 | CorMedix Inc. | Shares withheld for tax | −17,417 | $7.15 | $124,532 |
| Dec 18, 2025 | CorMedix Inc. | Option exercise | +30,000 | $4.43 | $132,900 |
| Dec 18, 2025 | CorMedix Inc. | Open-market sale | −30,000 | $12.00 | $360,000 |
| Oct 15, 2025 | Talphera Inc. | Grant or award | +6,397 | — | — |
| Sep 12, 2025 | CorMedix Inc. | Option exercise | +50,000 | $3.47 | $173,500 |
| Sep 12, 2025 | CorMedix Inc. | Open-market sale | −50,000 | $13.00 | $650,000 |
| May 10, 2025 | CorMedix Inc. | Shares withheld for tax | −21,225 | $11.66 | $247,484 |
| Apr 1, 2025 | CorMedix Inc. | Option exercise | +59,170 | $3.38 | $199,995 |
| Jan 17, 2025 | CorMedix Inc. | Grant or award | +187,500 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.